https://www.socictopen.socict.org/files/original/c65095760f263fe9892212291aad9ed2.pdf 3a7d0004d660237c2eecd2d8cca42bce Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Severe bradyarrhythmia requiring temporary pacemaker in a COVID-19 patient receiving lopinavir/ritonavir treatment: a case report Creator An entity primarily responsible for making the resource Zhenisgul Sh. Tlegenova, Bekbolat Zholdin, Meirambek S. Kurmangazin, Bulat K. Khamidulla, Zhambul E. Zhailybaev Description An account of the resource A 74-year-old Asian female with a history of hypertension and chronic obstructive pulmonary disease was admitted to hospital for coughing, shortness of breath and fatigue; her nasopharyngeal swab was positive for COVID-19. Lopinavir/ritonavir 800mg/200 mg, daily was started. On the third day of antiviral therapy, the patient complained of dizziness, nausea, she was disorientated, and electrocardiogram showed sinus arrest, junctional escape rhythm 36 beats per min. Patient was successfully treated by temporary pacemaker, normal sinus rhythm was reverted on a 3rd  day after stopping the lopinavir/ritonavir treatment. She was discharged home in stable condition. Bradyarrhythmia in form of sinus arrest can develop during treatment with lopinavir/ritonavir. The temporal nature of the observed changes and the ECG finding suggests the use of L/R contributed to the changes. This case highlights off-label prescribing lopinavir/ritonavir outside of a clinical trial setting should be avoided until the data have proven that treatment benefit over placebo. Date A point or period of time associated with an event in the lifecycle of the resource 2020 Subject The topic of the resource covid-19, lopinavir, Pacemaker, Ritonavir, Complication, bradyarrhythmia, Sinus arrest, Junctional rhythm Identifier An unambiguous reference to the resource within a given context 10.24969/hvt.2020.198 Source A related resource from which the described resource is derived Heart Vessels and Transplantation Publisher An entity responsible for making the resource available Center for Scientific Research and Development of Education. Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Diseases of the circulatory (Cardiovascular) system